KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Current Assets (2016 - 2026)

Supernus Pharmaceuticals has reported Current Assets over the past 15 years, most recently at $644.2 million for Q4 2025.

  • Quarterly Current Assets fell 6.11% to $644.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $644.2 million through Dec 2025, down 6.11% year-over-year, with the annual reading at $644.2 million for FY2025, 6.11% down from the prior year.
  • Current Assets was $644.2 million for Q4 2025 at Supernus Pharmaceuticals, up from $593.9 million in the prior quarter.
  • Over five years, Current Assets peaked at $883.3 million in Q1 2023 and troughed at $423.5 million in Q2 2023.
  • The 5-year median for Current Assets is $632.2 million (2021), against an average of $623.1 million.
  • Year-over-year, Current Assets surged 55.38% in 2023 and then crashed 38.38% in 2024.
  • A 5-year view of Current Assets shows it stood at $601.6 million in 2021, then increased by 22.04% to $734.2 million in 2022, then crashed by 32.83% to $493.1 million in 2023, then soared by 39.13% to $686.1 million in 2024, then dropped by 6.11% to $644.2 million in 2025.
  • Per Business Quant, the three most recent readings for SUPN's Current Assets are $644.2 million (Q4 2025), $593.9 million (Q3 2025), and $738.9 million (Q2 2025).